The impact of second allogeneic hematopoietic stem cell transplantation as salvage therapy for hematologic diseases after a first allogeneic transplantation.

  • Abstract
  • Literature Map
  • Similar Papers
Abstract
Translate article icon Translate Article Star icon

The impact of second allogeneic hematopoietic stem cell transplantation as salvage therapy for hematologic diseases after a first allogeneic transplantation.

Similar Papers
  • Research Article
  • Cite Count Icon 33
  • 10.1016/j.bbmt.2010.10.031
Minimal Residual Disease following Allogeneic Hematopoietic Stem Cell Transplantation
  • Nov 1, 2010
  • Biology of Blood and Marrow Transplantation
  • Nicolaus Kröger + 2 more

Minimal Residual Disease following Allogeneic Hematopoietic Stem Cell Transplantation

  • Research Article
  • Cite Count Icon 29
  • 10.1016/j.bbmt.2011.06.010
EBMT Risk Score Predicts Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Who Have Failed a Previous Transplantation Procedure
  • Jun 30, 2011
  • Biology of Blood and Marrow Transplantation
  • Katayoun Rezvani + 15 more

EBMT Risk Score Predicts Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Who Have Failed a Previous Transplantation Procedure

  • Research Article
  • Cite Count Icon 64
  • 10.1016/j.bbmt.2011.07.019
The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Update of the 2006 Evidence-Based Review
  • Jul 29, 2011
  • Biology of Blood and Marrow Transplantation
  • Denise M Oliansky + 7 more

The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Update of the 2006 Evidence-Based Review

  • Research Article
  • Cite Count Icon 100
  • 10.1016/j.bbmt.2010.05.007
Conditioning with Treosulfan and Fludarabine followed by Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
  • May 26, 2010
  • Biology of Blood and Marrow Transplantation
  • Eneida R Nemecek + 17 more

Conditioning with Treosulfan and Fludarabine followed by Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies

  • Research Article
  • Cite Count Icon 31
  • 10.1016/j.exphem.2012.06.003
Impact of anti-HLA antibodies on allogeneic hematopoietic stem cell transplantation outcomes after reduced-intensity conditioning regimens
  • Jun 12, 2012
  • Experimental Hematology
  • Marie Detrait + 14 more

Impact of anti-HLA antibodies on allogeneic hematopoietic stem cell transplantation outcomes after reduced-intensity conditioning regimens

  • Research Article
  • Cite Count Icon 63
  • 10.1016/j.exphem.2008.01.017
Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire
  • Mar 17, 2008
  • Experimental Hematology
  • Mauricette Michallet + 17 more

Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire

  • Research Article
  • Cite Count Icon 102
  • 10.1016/j.bbmt.2003.11.005
A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipients.
  • Apr 1, 2004
  • Biology of Blood and Marrow Transplantation
  • Ifeyinwa Osunkwo + 13 more

A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipients.

  • Research Article
  • Cite Count Icon 52
  • 10.1016/j.bbmt.2010.05.005
NCI First International Workshop on the Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: Report from the Committee on Prevention of Relapse Following Allogeneic Cell Transplantation for Hematologic Malignancies
  • May 24, 2010
  • Biology of Blood and Marrow Transplantation
  • Edwin P Alyea + 9 more

NCI First International Workshop on the Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: Report from the Committee on Prevention of Relapse Following Allogeneic Cell Transplantation for Hematologic Malignancies

  • Research Article
  • Cite Count Icon 55
  • 10.1016/j.bbmt.2011.07.012
Genome-wide Profiling in AML Patients Relapsing after Allogeneic Hematopoietic Cell Transplantation
  • Jul 23, 2011
  • Biology of Blood and Marrow Transplantation
  • Miguel Waterhouse + 5 more

Genome-wide Profiling in AML Patients Relapsing after Allogeneic Hematopoietic Cell Transplantation

  • Research Article
  • Cite Count Icon 30
  • 10.1016/j.bbmt.2012.04.002
Costs and Cost-Effectiveness of Allogeneic Stem Cell Transplantation in Children Are Predictable
  • Apr 5, 2012
  • Biology of Blood and Marrow Transplantation
  • Susanne Matthes-Martin + 8 more

Costs and Cost-Effectiveness of Allogeneic Stem Cell Transplantation in Children Are Predictable

  • Research Article
  • Cite Count Icon 33
  • 10.1016/j.bbmt.2010.06.005
Leukemia Lineage-Specific Chimerism Analysis and Molecular Monitoring Improve Outcome of Donor Lymphocyte Infusions
  • Jun 10, 2010
  • Biology of Blood and Marrow Transplantation
  • Darius Sairafi + 5 more

Leukemia Lineage-Specific Chimerism Analysis and Molecular Monitoring Improve Outcome of Donor Lymphocyte Infusions

  • Research Article
  • Cite Count Icon 136
  • 10.1016/j.bbmt.2010.08.001
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
  • Aug 8, 2010
  • Biology of Blood and Marrow Transplantation
  • David L Porter + 16 more

NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation

  • Research Article
  • Cite Count Icon 58
  • 10.1016/j.bbmt.2010.05.015
Feasibility and Safety of Adoptive Immunotherapy with CIK Cells after Cord Blood Transplantation
  • Jun 1, 2010
  • Biology of Blood and Marrow Transplantation
  • Martino Introna + 9 more

Feasibility and Safety of Adoptive Immunotherapy with CIK Cells after Cord Blood Transplantation

  • Research Article
  • Cite Count Icon 23
  • 10.1016/j.bbmt.2019.06.016
Induction, Bridging, or Straight Ahead: The Ongoing Dilemma of Allografting in Advanced Myelodysplastic Syndrome
  • Jun 20, 2019
  • Biology of Blood and Marrow Transplantation
  • Nicolaus Kröger

Induction, Bridging, or Straight Ahead: The Ongoing Dilemma of Allografting in Advanced Myelodysplastic Syndrome

  • Research Article
  • Cite Count Icon 1
  • 10.1182/blood-2024-205435
Safety and Efficacy of Pomalidomide and Azacitidine Combination in MRD-Guided Preemptive Treatment of Acute Leukemia after Allogeneic Stem Cell Transplantation
  • Nov 5, 2024
  • Blood
  • Lu Wang + 7 more

Safety and Efficacy of Pomalidomide and Azacitidine Combination in MRD-Guided Preemptive Treatment of Acute Leukemia after Allogeneic Stem Cell Transplantation

Save Icon
Up Arrow
Open/Close
Notes

Save Important notes in documents

Highlight text to save as a note, or write notes directly

You can also access these Documents in Paperpal, our AI writing tool

Powered by our AI Writing Assistant